|
Population Genomics: Whole-Genome Analysis Of Polymorphism And Divergence In Drosophila Simulans (Medical News Today)
Population genomics, the study of genome-wide patterns of sequence variation within and between closely related species, can provide a comprehensive view of the relative importance of mutation, recombination, natural selection, and genetic drift in evolution. It can also provide fundamental insights into the biological attributes of organisms specifically shaped by adaptation. [click link for ...
(Nov 6, 2007)
Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function (Science Daily)
Children possessing a gene known to increase Alzheimer's disease risk already show signs of reduced cognitive function a new study has found. Scientists discovered that 7- to 10-year-olds with a member of a family of genes implicated in development, nerve cell regeneration and neuroprotection display reduced spatial learning and memory, associated with later-life cognitive impairments. This ...
(Nov 6, 2007)
Genome Study Charts Genetic Landscape Of Lung Cancer (Science Daily)
An international team of scientists have announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world's leading cause of cancer deaths. Comprehensive analysis of DNA from human lung tumors uncovers more than 50 common genetic abnormalities, less than half involve known cancer genes.
(Nov 6, 2007)
The Race for Biofuels Driving Alternative Sources of Biomass (Newswise)
Two papers presented at the Annual Meetings of the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America, will examine the future of biomass for biofuel production and will look at how several species, dependent on region, could be grown for biofuels.
(Nov 6, 2007)
Colorectal Cancer Patients May Find Curry-Derived Molecule Too Spicy (Medical News Today)
Curcumin, the yellowish component of turmeric that gives curry its flavor, has long been noted for its potential anti-cancer properties. Researchers from Tohoku University in Sendai, Japan, report on an apparent improvement upon nature: two molecular analogues of curcumin that demonstrate even greater tumor suppressive properties. [click link for full article]
(Nov 6, 2007)
Navigenics Launches With Preeminent Team of Advisers, Partners and Investors (PR Newswire via Yahoo! Finance)
Navigenics, Inc. launched officially today, naming a team of advisers and investors from leading communities in science, medicine, technology and public policy who are supporting the company.
(Nov 6, 2007)
Young Onset Breast Cancer Patients Study Reveals Rare Cancer-Causing Syndrome (Medical News Today)
A rare hereditary disorder that strongly predisposes carriers to develop cancer at an early age has been found in an Asian female, report researchers at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.Generally, a person should have two normal copies of the powerful p53 tumor suppressor gene. [click link for full article]
(Nov 6, 2007)
All-Purpose Radiation Protection From Common Antioxidants (Medical News Today)
Two common dietary molecules found in legumes and bran could protect DNA from the harmful effects of radiation, researchers from the University of Maryland report. [click link for full article]
(Nov 6, 2007)
Soy could help reduce fat gene (Food Navigator)
06/11/2007 - The soy compound lunasin has been shown to inhibit the expression of a gene responsible for internal cholesterol production, Soy Labs' scientists have said.
(Nov 6, 2007)
New Reagent From Applied Biosystems Accelerates Real-Time PCR (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, today introduced a new master mix reagent designed to accelerate real-time PCR . Fast SYBR Green® Master Mix provides life scientists with a new choice in fast-enabled PCR chemistries that is expected to deliver results in less than half the time of standard SYBR green reagents.1 Fast SYBR Green Master Mix establishes ...
(Nov 6, 2007)
Affymetrix GeneChip(R) Command Console(R) Software Simplifies Microarray Processing and Analysis Workflows (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Affymetrix Inc. today announced the full commercial launch of Affymetrix GeneChip® Command Console® Software, one part of a software suite that enables researchers and clinicians to extract and analyze microarray data faster than ever before.
(Nov 6, 2007)
Study Identifies Novel Gene Alterations In Lung Cancer (BioresearchOnline)
An international team of scientists, supported in part by the National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), today announced that its systematic effort to map the genomic changes underlying lung cancer has uncovered a critical gene alteration not previously linked to any form of cancer
(Nov 6, 2007)
Criticality of micro RNAs in Functional Genomics Heightens micro RNA R&D (Business Wire via Yahoo! Finance)
PALO ALTO, Calif.----Researchers and companies worldwide have realized the importance of RNA interference as a novel tool for analyzing gene function and identifying new drug targets and target validation.
(Nov 6, 2007)
Powerful Integration Of Lipid Metabolic Profiling With Gene Expression Analysis (BioresearchOnline)
A recently published research article in the "Journal of Proteome Research", authored by researchers from the Nestlé Reserarch Center, Genomatix Software GmbH, Rosetta Inpharmatics LLC, CXR Biosciences Ltd, the Cancer Research UK Molecular Pharmacology Unit demonstrates the synergisms and enhanced analytic power of the combination of thorough metabolic profiling with the unique and proprietary ...
(Nov 6, 2007)
FAYETTEVILLE : Stenken honored as newest recruit (NWAnews.com)
FAYETTEVILLE — Evidence of the Campaign for the 21st Century can be seen throughout the University of Arkansas campus, Chancellor John A. White said Monday. (Arkansas Democrat-Gazette Northwest Edition)
(Nov 6, 2007)
Optimizing Compilers target multi-core, 64-bit processors. (ThomasNet)
Bringing MPI debugging and profiling to Linux desktop, PGI® v7.1 provides Fortran, C, and C++ compilers and development tools that convert software programs into binary instructions that computer can understand. Best-practices software components are provided for developing parallel applications to multi-core Linux desktops, and support for OpenMP and MPI - including graphical OpenMP and MPI ...
(Nov 6, 2007)
New Reagent From Applied Biosystems Accelerates Real-Time PCR (BioresearchOnline)
Applied Biosystems, an Applera Corporation business, today introduced a new master mix reagent designed to accelerate real-time PCR (polymerase chain reaction)
(Nov 6, 2007)
Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: (PR Newswire via Yahoo! Finance)
Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology, announced today that Virginia Commonwealth University School of Medicine has initiated an investigational study of the Pathwork Tissue of Origin Test.
(Nov 6, 2007)
CLC bio Customized Software Supports Abcam's Monoclonal Development Capability (Press Release Network)
CLC bio, the premier bioinformatics solution provider, and Abcam, the world-leading research antibody supplier, today announced that CLC bio has met the first important milestone of the two companies' collaboration: the development of a customized epitope prediction software solution to augment Abcam's high through-put monoclonal antibody development programme. [Wired by: PressReleaseNetwork.com]
(Nov 6, 2007)
UB researchers receive Oishei grant (BizJournals)
The University at Buffalo will deepen its studies in psychiatry with a $148,328 grant from the John R. Oishei Foundation.
(Nov 6, 2007)
/C O R R E C T I O N -- Pathwork Diagnostics/ (PR Newswire via Yahoo! Finance)
Based Diagnostic Test, issued earlier today by Pathwork Diagnostics over PR Newswire, we are advised by the company that the headline should be formatted as follows:
(Nov 6, 2007)
TRADE NEWS: Agilent Technologies' New Accurate-Mass TOF and Q-TOF LC/MS Provide Unmatched Performance (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Agilent Technologies Inc. today introduced the Agilent 6220 Accurate-Mass time-of-flight and 6520 Accurate-Mass quadrupole time-of-flight liquid chromatography/mass spectrometry systems, delivering unmatched mass accuracy, mass resolution, sensitivity and speed for proteomics, metabolomics, product degradation and other complex experiments.
(Nov 6, 2007)
Cray Integrates DRC's Reconfigurable Coprocessor in Next Generation Hybrid Computing Platform (Business Wire via Yahoo! Finance)
SUNNYVALE, Calif.----DRC Computer Corporation, the leading provider of dynamically reconfigurable coprocessor modules, today announced that global supercomputer leader Cray Inc. will include DRC's Reconfigurable Processor Unit in an optional reconfigurable computing blade in its newly launched hybrid supercomputer, the Cray XT5hTM system.
(Nov 6, 2007)
Novel Gene Alterations Identified In Lung Cancer (Science Daily)
Unprecedented study of the genomic landscape of lung cancer identifies key gene alteration not previously implicated in any form of cancer. The study also revealed more than 50 genomic regions that are frequently gained or lost in lung adenocarcinoma, the most common type of lung cancer in the United States.
(Nov 6, 2007)
Powerful Integration Of Lipid Metabolic Profiling With Gene Expression Analysis (Medical News Today)
A recently published research article in the Journal of Proteome Research, authored by researchers from the Nestle Reserarch Center, Genomatix Software GmbH, Rosetta Inpharmatics LLC, CXR Biosciences Ltd, the Cancer Research UK Molecular Pharmacology Unit demonstrates the synergisms and enhanced anal [click link for full article]
(Nov 6, 2007)
Soy could help reduce fat gene (Nutraingredients.com)
11/6/2007 - The soy compound lunasin has been shown to inhibit the expression of a gene responsible for internal cholesterol production, Soy Labs' scientists have said.
(Nov 6, 2007)
On Being Human (Duke University)
Durham, NC -- You can’t change human nature — or can you? Advances in genomics, robotics, neuroscience and evolutionary theory seem to call into question what sets humans apart from other creatures.
(Nov 6, 2007)
Navigenics Launches With Preeminent Team of Advisers, Partners and Investors (The San Francisco Examiner)
Redwood Shores, Calif. ( Map ) - REDWOOD SHORES, Calif., Nov. 6 /PRNewswire/ -- Navigenics, Inc. launched officially today, naming a team of advisers and investors from leading communities in science, medicine, technology and public policy who are supporting the company.
(Nov 6, 2007)
Children with apoE4 gene show reduced cognitive function (News-Medical-Net)
Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.
(Nov 6, 2007)
BIO Welcomes New Report Detailing Policy Options to Ensure Responsible Use of Synthetic Biology (Business Wire via Yahoo! Finance)
WASHINGTON----The Biotechnology Industry Organization today applauded the report "Synthetic Genomics: Options for Governance," released by the J. Craig Venter Institute, the Center for Strategic and International Studies, and the Massachusetts Institute of Technology.
(Nov 6, 2007)
BIO Welcomes New Report Detailing Policy Options to Ensure Responsible Use of Synthetic Biology (BIO)
WASHINGTON, D.C. (November 6, 2007) – The Biotechnology Industry Organization (BIO) today applauded the report “Synthetic Genomics: Options for Governance,” released by the J. Craig Venter Institute, the Center for Strategic and International Studies, and the Massachusetts Institute of Technology.
(Nov 6, 2007)
Consumer Genomics Startup Navigenics Makes Official Debut; Names Sue Siegel as Director (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
(Nov 6, 2007)
BIO-Europe 2007 Exhibitor Profiles (Business Wire via Yahoo! Finance)
HAMBURG, Germany----BIO-Europe 2007 takes place November 12-14, 2007 at the Congress Center Hamburg. Listed below are BIO-Europe exhibitor profiles. For in-depth information about the event, visit http://www.ebdgroup.com/bioeur
(Nov 6, 2007)
Gene expression profiling of dengue virus infection in cell lines and patients (EurekAlert!)
Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease.
(Nov 7, 2007)
Gene Expression Profiling Of Dengue Virus Infection In Cell Lines And Patients (Medical News Today)
Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease. Dengue is the most prevalent mosquito-born viral disease affecting humans. [click link for full article]
(Nov 7, 2007)
Drug slows prostate tumor growth by keeping vitamin A active (EurekAlert!)
SINGAPORE -- A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and “promiscuous” agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore (UMB).
(Nov 7, 2007)
Synamatix Announces Collaboration with Emory University on Small RNA Based Brain Disease Studies (PRWeb via Yahoo! News)
Synamatix announced today a research collaboration based upon neurological disease analysis with the Emory University School of Medicine. Synamatix's role in this research will be to apply its novel SynaBASE™ and SXOligoSearch™ pattern-finding applications to process and analyse small RNAs generated from mouse brain cognitive disease studies.
(Nov 7, 2007)
China Patent and Trademark Office Grants Patent for F351, GNI's Key Therapeutic Product for Liver Disease (Business Wire via Yahoo!7 Finance)
GNI Ltd, a leading biopharmaceutical company in Japan and China, is pleased to announce that China's Patent & Trademark Office has granted Shanghai Genomics, GNI's wholly owned China subsidiary, regional patent rights relating to one of its lead drug candidates, F351 and its use (China Patent ZL 200380110691.0).
(Nov 7, 2007)
China Patent and Trademark Office Grants Patent for F351, GNI's Key Therapeutic Product for Liver Disease (Business Wire via Yahoo! Finance)
TOKYO----GNI Ltd, a leading biopharmaceutical company in Japan and China, is pleased to announce that China's Patent & Trademark Office has granted Shanghai Genomics, GNI's wholly owned China subsidiary, regional patent rights relating to one of its lead drug candidates, F351 and its use .
(Nov 7, 2007)
Applied Biosystems launches next-generation DNA sequencing platform (PharmaBiz)
Applied Biosystems, an Applera Corporation Business, has entered a new era of life-science research by announcing the worldwide commercial availability of the SOLiD System, the company's highly anticipated next-generation DNA sequencing platform.
(Nov 7, 2007)
Synamatix Announces Collaboration with Emory University on Small RNA Based Brain Disease Studies (PRWeb)
Synamatix announced today a research collaboration based upon neurological disease analysis with the Emory University School of Medicine. Synamatix's role in this research will be to apply its novel SynaBASE™ and SXOligoSearch™ pattern-finding applications to process and analyse small RNAs generated from mouse brain cognitive disease studies. (PRWeb Nov 7, 2007) Post Comment:Trackback URL: ...
(Nov 7, 2007)
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays (Business Wire via Yahoo! Finance)
LYON, France----Reportlinker.com announces that a new market research report related to the American biotechnology industry is available in its catalogue.
(Nov 7, 2007)
BASF's Amflora Potato Delivers Gene-Modified Profits (Update2) (Bloomberg.com)
Nov. 7 (Bloomberg) -- BASF AG, the world's largest chemical maker, is weeks away from challenging European resistance to genetically modified plants with a potato that will reap profit and share gains along with other bio-engineered crops.
(Nov 7, 2007)
WELLCOME TRUST PROVIDES £6.2 MILLION BACKING FOR DUNDEE LIFE SCIENCES (BioDundee)
The University of Dundee has been awarded more than £6 million in grants from the Wellcome Trust to establish a major new research centre in the College of Life Sciences and add new infrastructure for the Drug Discovery Unit.
(Nov 7, 2007)
BIO Welcomes New Report Detailing Policy Options To Ensure Responsible Use Of Synthetic Biology, USA (Medical News Today)
The Biotechnology Industry Organization (BIO) applauded the report "Synthetic Genomics: Options for Governance," released by the J. Craig Venter Institute, the Center for Strategic and International Studies, and the Massachusetts Institute of Technology. [click link for full article]
(Nov 7, 2007)
Three New Studies Show Benefits of NuVim's Key Ingredient (Business Wire via Yahoo! Finance)
PARAMUS, N.J.----NuVim, Inc. announced today that three studies were recently published relating to GTC Nutrition's flagship ingredient solution NutraFlora® (short-chain fructooligosaccharides prebiotic fiber).
(Nov 7, 2007)
Invitrogen and Biosynth Partner to Launch Rapid Detection Products for MRSA Contamination in Hospitals (Business Wire via Yahoo! Finance)
CARLSBAD, Calif. & STAAD, Switzerland----Invitrogen , a provider of essential life science technologies for research, production and diagnostics, and Biosynth AG, a manufacturer of specialty chemicals for the life science and pharmaceutical industries, announced the launch of a novel, fluorescence-based culture medium for rapid detection of methicillin-resistant Staphylococcus aureus in ...
(Nov 7, 2007)
BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals (PR Newswire via Yahoo! Finance)
BioSpace, the leading biotech job board and life science career fair company, welcomed over 300 biotechnology and pharmaceutical job seekers to the BioSpace Career Fair on October 23, 2007 in Bethesda, MD.
(Nov 7, 2007)
Invitrogen and Biosynth Partner to Launch Rapid Detection Products for MRSA Contamination in Hospitals (FinanzNachrichten)
Invitrogen (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and Biosynth AG, a manufacturer of specialty chemicals for the life science and pharmaceutical industries, announced the launch of a novel, fluorescence-based culture medium for rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and medical settings.
(Nov 7, 2007)
Mitrionics and SGI Customers Validate Global Demand for Accelerated FPGA Technology (Marketwire via Yahoo! Finance)
Mitrionics(TM), Inc., developer of the Mitrion(TM) Software Acceleration Platform and the Mitrion Virtual Processor, today announced a growing number of global companies, organizations, and universities that are using their accelerated FPGA technology platform and NCBI BLAST-n application. The Mitrion-Accelerated BLAST application runs on a turnkey SGI® RASC(TM) RC100 blade system equipped with ...
(Nov 7, 2007)
|
